BRIEF TOC
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Antihelminthics Market, by Type
6.1 Introduction
6.2 Benzimidazoles
Market Estimates & Forecast, 2020 – 2027
6.2.1 Albendazole
Market Estimates & Forecast, 2020 – 2027
6.2.2 Mebendazole
Market Estimates & Forecast, 2020 – 2027
6.2.3 Benzimidazoles
Market Estimates & Forecast, 2020 – 2027
6.2.4 Thiabendazole
Market Estimates & Forecast, 2020 – 2027
6.2.5 Others
Market Estimates & Forecast, 2020 – 2027
6.3 Abamectin
Market Estimates & Forecast, 2020 – 2027
6.4 Salicylanilides
Market Estimates & Forecast, 2020 – 2027
6.5 Praziquantel
Market Estimates & Forecast, 2020 – 2027
6.6 Others
Market Estimates & Forecast, 2020 – 2027
Chapter 7. Global Antihelminthics Market, by Applications
7.1 Introduction
7.2 Schistosomiasis
Market Estimates & Forecast, 2020 – 2027
7.3 Fasciolasis
Market Estimates & Forecast, 2020 – 2027
7.4 Filariasis
Market Estimates & Forecast, 2020 – 2027
7.5 Angiostrongylosis
Market Estimates & Forecast, 2020 – 2027
7.6 Ascariasis
Market Estimates & Forecast, 2020 – 2027
7.7 Giardiasis
Market Estimates & Forecast, 2020 – 2027
7.8 Others
Market Estimates & Forecast, 2020 – 2027
Chapter 8 Global Antihelminthics Market, by End User
8.1 Introduction
8.2 Hospitals
8.2.1 Market Estimates & Forecast, 2020 – 2027
8.3 Clinics
8.2.2 Market Estimates & Forecast, 2020 – 2027
8.4 Others
Chapter 9. Global Antihelminthics Market, by Region
9.1 Introduction
9.2 America
9.2.1 North America
9.2.1.1 US
9.2.1.1 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of the Middle East & Africa
Chapter 10 Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Novartis AG
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 Abbott
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 ZEISS International
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Johnson & Johnson Services, Inc
11.4.1 Company Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Sanofi
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.6 Merck & Co., Inc.
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 GlaxoSmithKline plc
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Antihelminthics industry
Chapter 13 Appendix
LIST OF TABLES
Table 1 Antihelminthics Industry Synopsis, 2020 – 2027
Table 2 Global Antihelminthics Market Estimates and Forecast, 2020 – 2027, (USD Million)
Table 3 Global Antihelminthics Market by Region, 2020 – 2027, (USD Million)
Table 4 Global Antihelminthics Market by Types, 2020 – 2027, (USD Million)
Table 5 Global Antihelminthics Market by Applications, 2020 – 2027, (USD Million)
Table 6 Global Antihelminthics Market by End Users, 2020 – 2027, (USD Million)
Table 7 North America Antihelminthics Market by Types, 2020 – 2027, (USD Million)
Table 8 North America Antihelminthics Market by Applications, 2020 – 2027, (USD Million)
Table 9 North America Antihelminthics Market by End Users, 2020 – 2027, (USD Million)
Table 10 US Market by Types, 2020 – 2027, (USD Million)
Table 11 US Antihelminthics Market by Applications, 2020 – 2027, (USD Million)
Table 12 US Antihelminthics Market by End Users, 2020 – 2027, (USD Million)
Table 13 Canada Market by Types, 2020 – 2027, (USD Million)
Table 14 Canada Antihelminthics Market by Applications, 2020 – 2027, (USD Million)
Table 15 Canada Antihelminthics Market by End Users, 2020 – 2027, (USD Million)
Table 16 South America Market by Types, 2020 – 2027, (USD Million)
Table 17 South America Antihelminthics Market by Applications, 2020 – 2027, (USD Million)
Table 18 South America Antihelminthics Market by End Users, 2020 – 2027, (USD Million)
Table 19 Europe Market by Types, 2020 – 2027, (USD Million)
Table 20 Europe Antihelminthics Market by Applications, 2020 – 2027, (USD Million)
Table 21 Europe Antihelminthics Market by End Users, 2020 – 2027, (USD Million)
Table 22 Western Europe Market by Types, 2020 – 2027, (USD Million)
Table 23 Western Europe Antihelminthics Market by Applications, 2020 – 2027, (USD Million)
Table 24 Western Europe Antihelminthics Market by End Users, 2020 – 2027, (USD Million)
Table 25 Eastern Europe Market by Types, 2020 – 2027, (USD Million)
Table 26 Eastern Europe Antihelminthics Market by Applications, 2020 – 2027, (USD Million)
Table 27 Eastern Europe Antihelminthics Market by End Users, 2020 – 2027, (USD Million)
Table 28 Asia Pacific Market by Types, 2020 – 2027, (USD Million)
Table 29 Asia Pacific Antihelminthics Market by Applications, 2020 – 2027, (USD Million)
Table 30 Asia Pacific Antihelminthics Market by End Users, 2020 – 2027, (USD Million)
Table 31 Middle East & Africa Market by Types, 2020 – 2027, (USD Million)
Table 32 Middle East & Africa Antihelminthics Market by Applications, 2020 – 2027, (USD Million)
Table 33 Middle East & Africa Antihelminthics Market by End Users, 2020 – 2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Antihelminthics Market
Figure 3 Segmentation Market Dynamics for Global Antihelminthics Market
Figure 4 Global Antihelminthics market Share, by type 2020
Figure 5 Global Antihelminthics market Share, by Applications 2020
Figure 6 Global Antihelminthics Market Share, by End Users, 2020
Figure 7 Global Antihelminthics Market Share, by Region, 2020
Figure 8 North America Antihelminthics Market Share, by Country, 2020
Figure 9 Europe Antihelminthics Market Share, by Country, 2020
Figure 10 Asia Pacific Antihelminthics Market Share, by Country, 2020
Figure 11 Middle East & Africa Antihelminthics Market Share, by Country, 2020
Figure 12 Global Antihelminthics Market: Company Share Analysis, 2020 (%)
Figure 13 Novartis AG: Key Financials
Figure 14 Novartis AG: Segmental Revenue
Figure 15 Novartis AG: Geographical Revenue
Figure 16 Abbott: Key Financials
Figure 17 Abbott: Segmental Revenue
Figure 18 Abbott: Geographical Revenue
Figure 19 ZEISS International: Key Financials
Figure 20 ZEISS International: Segmental Revenue
Figure 21 ZEISS International: Geographical Revenue
Figure 22 Johnson & Johnson Services, Inc.: Key Financials
Figure 23 Johnson & Johnson Services, Inc.: Segmental Revenue
Figure 24 Johnson & Johnson Services, Inc.: Geographical Revenue
Figure 25 Sanofi.: Key Financials
Figure 26 Sanofi.: Segmental Revenue
Figure 27 Sanofi.: Geographical Revenue
Figure 28 Merck & Co., Inc.: Key Financials
Figure 29 Merck & Co., Inc.: Segmental Revenue
Figure 30 Merck & Co., Inc.: Geographical Revenue
Figure 31 GlaxoSmithKline plc.: Key Financials
Figure 32 GlaxoSmithKline plc.: Segmental Revenue
Figure 33 GlaxoSmithKline plc.: Geographical Revenue
